HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476.

Abstract
A novel sodium-calcium ion channel modulator, RS-87476, reduced cerebral infarct size in cats subjected to permanent unilateral occlusion of the middle cerebral artery. Cerebral injury was assessed in vivo with a combination of magnetic resonance (MR) imaging and spectroscopy for 5-12 hours after occlusion and was compared with the area of histochemically ischemic brain tissue. Compared with infarcts in placebo-treated animals, infarcts in cats given RS-87476 were reduced by an average of 70% at the lowest dose, 75% at the intermediate dose, and 88% at the highest dose. Tissue edema, observed as areas of signal hyperintensity on diffusion- and T2-weighted spin-echo images, was confined to small regions of the parietal cortex and basal ganglia in drug-treated animals. Mean plasma levels of RS-87476 at the lowest dose were 13 ng/mL initially, falling to maintenance levels of 3-5 ng/mL; at the intermediate and highest doses, plasma levels of drug were approximately five- and 20-fold greater. The drug was only slightly hypotensive. At least part of the potent cerebroprotective effects of RS-87476 result from its ability to stabilize metabolic energy reserves, reduce lactate formation in ischemic tissues, and attenuate intracerebral edema.
AuthorsJ Kucharczyk, J Mintorovitch, M E Moseley, H S Asgari, R J Sevick, N Derugin, D Norman
JournalRadiology (Radiology) Vol. 179 Issue 1 Pg. 221-7 (Apr 1991) ISSN: 0033-8419 [Print] United States
PMID2006281 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Imidazoles
  • Piperazines
  • lifarizine
Topics
  • Animals
  • Brain (metabolism, pathology)
  • Brain Ischemia (complications, drug therapy, metabolism, pathology)
  • Cats
  • Cerebral Infarction (etiology, pathology)
  • Female
  • Imidazoles (administration & dosage, pharmacokinetics, therapeutic use)
  • Magnetic Resonance Imaging
  • Magnetic Resonance Spectroscopy
  • Male
  • Piperazines (administration & dosage, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: